Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 71,016 Less Arrow 0 Equal arrow 0
Financial expenses 5 More Arrow 240 More Arrow 318
Earnings before taxes -109,687 Less Arrow -209,110 More Arrow -192,990
EBITDA -124,661 Less Arrow -213,693 More Arrow -192,029
Total assets 781,368 Less Arrow 334,385 Less Arrow 225,868
Current assets 781,368 Less Arrow 332,879 Less Arrow 180,283
Current liabilities 47,351 Less Arrow 26,048 More Arrow 30,934
Equity capital 733,452 Less Arrow 305,873 Less Arrow 193,175
- share capital 76,175 Less Arrow 37,520 Less Arrow 27,347
Employees (average) 27 Less Arrow 25 Less Arrow 21

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 93.9% Less Arrow 91.5% Less Arrow 85.5%
Turnover per employee 2,630 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -154.5%
Return on assets (ROA) -14.0% Less Arrow -62.5% Less Arrow -85.3%
Current ratio 1650.2% Less Arrow 1277.9% Less Arrow 582.8%
Return on equity (ROE) -15.0% Less Arrow -68.4% Less Arrow -99.9%
Change turnover 71,016 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 4 More Arrow 5
Chg. No. of employees % 8% More Arrow 19% More Arrow 31%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.